-

Charlie Falcone Joins Korn Ferry as Senior Client Partner

LOS ANGELES--(BUSINESS WIRE)--Korn Ferry (NYSE: KFY) today announced Charles “Charlie” Falcone joined the firm as a senior client partner and global leader of the academic sector, including academic medicine and higher education and as the director of the Korn Ferry Physician Leadership Institute. He is based in Chicago.

Falcone joins Korn Ferry from a global executive search firm where he led the firm’s education practice, overseeing higher education, academic medicine, and digital education, and specialized in executive search and leadership advisory solutions for senior leadership across academics and healthcare. Falcone has over 30 years of clinical healthcare, executive search, and leadership advisory experience.

Previously, Falcone spent 12 years with another executive search firm as partner and managing director for the Chicago office and senior member of the healthcare practice. There, he specialized in recruiting senior and board members for academic and healthcare systems. Prior to that, he was the medical director of operating rooms and surgical services at Northwestern Memorial Hospital and clinical director for the Department of Anesthesiology. Falcone began his career on the faculty of Harvard Medical School and Beth Israel Deaconess Medical Center.

“Charlie has an exceptional reputation in the market and brings extensive advisory and search experience working on the successful recruitment of CEOs, chancellors, deans, presidents, chairs, chief medical officers, and board-level assignments for academic institutions, health systems, and health-related associations and societies. He will be a great asset to our team,” said Gregory Button, president, global healthcare services practice, Korn Ferry.

Falcone holds a M.D. from Pennsylvania State University College of Medicine and an MBA from Kellogg Graduate School of Management at Northwestern University. He performed his residency and fellowship in Anesthesiology at the Massachusetts General Hospital and Harvard Medical School.

About Korn Ferry

Korn Ferry is a global organizational consulting firm. We work with our clients to design optimal organization structures, roles, and responsibilities. We help them hire the right people and advise them on how to reward and motivate their workforce while developing professionals as they navigate and advance their careers.

Contacts

Erica Shannon
(214) 665-3040
Erica.shannon@kornferry.com

Korn Ferry

NYSE:KFY

Release Versions

Contacts

Erica Shannon
(214) 665-3040
Erica.shannon@kornferry.com

More News From Korn Ferry

Korn Ferry to Report Quarterly Earnings via Live Webcast on December 9, 2025

LOS ANGELES--(BUSINESS WIRE)--Korn Ferry (NYSE:KFY) today announced that the firm will release financial results for the second quarter of fiscal year 2026 (ended October 31, 2025) on Tuesday, December 9, 2025. A press release will be issued before the market opens on Tuesday, December 9, 2025, followed by a live webcast at 12:00 pm EST. What: Korn Ferry to Report Q2 FY2026 Earnings Investor Live Webcast When: 12:00 pm EST on Tuesday, December 9, 2025. Where: Live audio webcast and accompanying...

Korn Ferry to Participate in the Wells Fargo 9th Annual TMT Summit

LOS ANGELES--(BUSINESS WIRE)--Korn Ferry (NYSE: KFY) today announced it is participating in the Wells Fargo 9th Annual TMT Summit on Tuesday, November 18, 2025. Korn Ferry EVP, Chief Financial Officer and Chief Corporate Officer Robert Rozek and Korn Ferry Head of AI Strategy and Transformation Bryan Ackermann, will participate in a fireside chat beginning at 4:30 p.m. EST. The event will be broadcast live and accessible to the general public here. The event can also be accessed through Korn Fe...

Korn Ferry Announces $250 Million Increase in its Common Share Repurchase Program

LOS ANGELES--(BUSINESS WIRE)--Korn Ferry (NYSE:KFY), a global consulting firm, today announced that its Board of Directors has approved an increase to the Company’s existing share repurchase program. The Board has authorized the purchase of up to an additional $250 million of the Company’s shares, bringing the total available capacity under the existing program to $331.4 million. “We are pleased to announce another increase in our stock repurchase program as part of our balanced capital allocat...
Back to Newsroom